Physician profile
Philip V Tran
NPI 1538471438
$771.56
in general payments reported to CMS, 2019-2025
16 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $27.08 · 2021: $29.85 · 2022: $65.91 · 2023: $91.29 · 2024: $275 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $134.38 | 2023-2024 | Farxiga, Lokelma, Wainua |
| Abbvie INC. | $118.21 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $97.74 | 2019-2025 | Eliquis |
| Lilly USA, LLC | $80.26 | 2024 | Mounjaro |
| Janssen Pharmaceuticals, INC | $71.59 | 2019-2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $43.43 | 2019-2022 | |
| Aimmune Therapeutics, INC. | $34.53 | 2024 | |
| Novartis Pharmaceuticals Corporation | $33.96 | 2022-2024 | |
| Medtronic, INC. | $30.02 | 2024 | Linq II, Kyphon Express II Kyphopak Tray |
| Csl Behring | $23.59 | 2025 | Kcentra |
| Portola Pharmaceuticals, LLC | $20.04 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $18.15 | 2023 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.89 | 2024 | Jardiance |
| Allergan, INC. | $17.41 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.79 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.